Skip to content

Immunome, Inc.

IMNM

CIK 0001472012

← back to feed
Revenue (TTM)
$6.94M
−23.2% YoY Q1 May 2026
Net Income (TTM)
−$196.33M
+27.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.15
+51.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-3,033.9%
Q1 May 2026
Net Margin
-2,828.6%
Q1 May 2026
Free Cash Flow (TTM)
−$107.63M
Q1 May 2026
Cash
$582.69M
Q1 May 2026
Total Debt
$500K
Q1 May 2026
Shares Outstanding
113.25M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings